| Spider-venom peptides as therapeutics NJ Saez, S Senff, JE Jensen, SY Er, V Herzig, LD Rash, GF King Toxins 2 (12), 2851-2871, 2010 | 338 | 2010 |
| Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain JD Osteen, V Herzig, J Gilchrist, JJ Emrick, C Zhang, X Wang, J Castro, ... Nature 534 (7608), 494-499, 2016 | 287 | 2016 |
| Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads JK Klint, S Senff, DB Rupasinghe, SY Er, V Herzig, GM Nicholson, ... Toxicon 60 (4), 478-491, 2012 | 251 | 2012 |
| Spider-venom peptides as bioinsecticides MJ Windley, V Herzig, SA Dziemborowicz, MC Hardy, GF King, ... Toxins 4 (3), 191-227, 2012 | 247 | 2012 |
| ArachnoServer 2.0, an updated online resource for spider toxin sequences and structures V Herzig, DLA Wood, F Newell, PA Chaumeil, Q Kaas, GJ Binford, ... Nucleic acids research 39 (suppl_1), D653-D657, 2010 | 201 | 2010 |
| Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a JR Deuis, Z Dekan, JS Wingerd, JJ Smith, NR Munasinghe, RF Bhola, ... Scientific reports 7 (1), 40883, 2017 | 145 | 2017 |
| Selective NaV1. 1 activation rescues Dravet syndrome mice from seizures and premature death KL Richards, CJ Milligan, RJ Richardson, N Jancovski, M Grunnet, ... Proceedings of the National Academy of Sciences 115 (34), E8077-E8085, 2018 | 135 | 2018 |
| Animal toxins—Nature’s evolutionary-refined toolkit for basic research and drug discovery V Herzig, B Cristofori-Armstrong, MR Israel, SA Nixon, I Vetter, GF King Biochemical pharmacology 181, 114096, 2020 | 126 | 2020 |
| Effects of MPEP on locomotion, sensitization and conditioned reward induced by cocaine or morphine V Herzig, WJ Schmidt Neuropharmacology 47 (7), 973-984, 2004 | 126 | 2004 |
| The insecticidal potential of venom peptides JJ Smith, V Herzig, GF King, PF Alewood Cellular and Molecular Life Sciences 70, 3665-3693, 2013 | 118 | 2013 |
| The cystine knot is responsible for the exceptional stability of the insecticidal spider toxin ω-Hexatoxin-Hv1a V Herzig, GF King Toxins 7 (10), 4366-4380, 2015 | 113 | 2015 |
| ArachnoServer 3.0: an online resource for automated discovery, analysis and annotation of spider toxins SS Pineda, PA Chaumeil, A Kunert, Q Kaas, MWC Thang, L Le, M Nuhn, ... Bioinformatics 34 (6), 1074-1076, 2018 | 110 | 2018 |
| Dangerous arachnids—Fake news or reality? TJ Hauke, V Herzig Toxicon 138, 173-183, 2017 | 90 | 2017 |
| Identification and characterization of ProTx-III [μ-TRTX-Tp1a], a new voltage-gated sodium channel inhibitor from venom of the tarantula Thrixopelma pruriens FC Cardoso, Z Dekan, KJ Rosengren, A Erickson, I Vetter, JR Deuis, ... Molecular pharmacology 88 (2), 291-303, 2015 | 90 | 2015 |
| Seven novel modulators of the analgesic target NaV1.7 uncovered using a high‐throughput venom‐based discovery approach JK Klint, JJ Smith, I Vetter, DB Rupasinghe, SY Er, S Senff, V Herzig, ... British journal of pharmacology 172 (10), 2445-2458, 2015 | 90 | 2015 |
| A cell-penetrating scorpion toxin enables mode-specific modulation of TRPA1 and pain JVL King, JJ Emrick, MJS Kelly, V Herzig, GF King, KF Medzihradszky, ... Cell 178 (6), 1362-1374. e16, 2019 | 89 | 2019 |
| The assassin bug Pristhesancus plagipennis produces two distinct venoms in separate gland lumens AA Walker, ML Mayhew, J Jin, V Herzig, EAB Undheim, A Sombke, ... Nature communications 9 (1), 755, 2018 | 84 | 2018 |
| A Proteomics and Transcriptomics Investigation of the Venom from the Barychelid Spider Trittame loki (Brush-Foot Trapdoor) EAB Undheim, K Sunagar, V Herzig, L Kely, DHW Low, TNW Jackson, ... Toxins 5 (12), 2488-2503, 2013 | 83 | 2013 |
| Repeated treatment with the NMDA antagonist MK-801 disrupts reconsolidation of memory for amphetamine-conditioned place preference R Sadler, V Herzig, WJ Schmidt Behavioural pharmacology 18 (7), 699-703, 2007 | 81 | 2007 |
| Effects of MPEP on expression of food‐, MDMA‐or amphetamine‐conditioned place preference in rats V Herzig, E Capuani, KA Kovar, W Schmidt Addiction biology 10 (3), 243-249, 2005 | 81 | 2005 |
Glenn F. KingProfessor, Institute for Molecular Bioscience在 imb.uq.edu.au 的电子邮件经过验证
